Concepedia

Publication | Closed Access

Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3)

DOI

323

Citations

26

References

2014

Year

Guillermo E. Umpierrez, Santiago Tofé, Federico Pérez Manghi, Linda Shurzinske, V. Pechtner
Diabetes Care

Abstract

Dulaglutide improves glycemic control and is well tolerated as monotherapy in patients with early stage type 2 diabetes.

References

YearCitations

Page 1